Integrative Genomic, Single-Cell, and Functional Profiling of the CD48-CD244 Axis and NK-Cell Dysfunction in Multiple Myeloma
Bonell Patiño-EscobariD, Torsten SteinbrunniD, Lucy Maritza Pérez LugoiD, Sham RampersaudiD, Daniel Dirck WalleriD, Huimin GengiD, Fernando Salangsang, Paul J. Phojanakong, Juan Antonio Camara Serrano, Yan Zeng, Veronica SteriiD, Oscar A. AguilariD, Constantine S. MitsiadesiD, Arun P. WiitaiD
Abstract
Multiple myeloma (MM) orchestrates immune evasion by subverting natural killer (NK) cell function. CD48, one of the most abundant NK-ligands on MM cells, paradoxically enhances NK-cell activation yet is associated with high-risk cytogenetics and poor patient survival. We integrated multi-omics (bulk and single-cell RNA-seq, ATAC-seq), genome-wide CRISPR-KO/a screens, and machine learning to dissect CD48 regulation and function. In human MM and V{kappa}*MYC mice scRNA-seq datasets, NK cells exhibit stepwise increases in inflammatory and exhaustion signatures and loss of cytotoxic potential as disease progresses. In vitro co-culture assays show CD48 overexpression on MM enhances initial NK-cell cytotoxicity and cytokine secretion, whereas chronic exposure leads to ex vivo NK dysfunction. In vivo, CD48-overexpressing V{kappa}*MYC tumors progress more slowly and extend host survival, while NK-cell depletion accelerates disease. These findings support a context-dependent role for CD48, potentiating acute NK responses while coexisting with chronic NK exhaustion, and suggest strategies to modulate CD48 for therapeutic benefit.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inflamed Natural Killer cells with adhesion defects are associated with a poor prognosis in Multiple Myeloma
Eve Blanquart, Rüçhan Ekren, … Ludovic Martinet·BloodPeer-reviewed·Jun 14, 2024
- Single-cell transcriptomic analysis of NK cell dynamics in myeloma patients reveal persistent reduction of cytotoxic NK cells from diagnosis to relapse
S. Tahri, M. M. E. de Jong, … T. Cupedo·bioRxiv·Jul 5, 2023
- Single-cell profiling of human bone marrow reveals multiple myeloma progression is accompanied by an increase in CD56bright bone marrow resident NK cells.
Elise Rees, Isabella Sodi, … Kwee Yong·bioRxiv·Feb 26, 2025
- NK cells control the progression of myelodysplastic syndrome but become initial disease target in NUP98-HOXD13 mouse model
Gladys Telliam Dushime, Maciej Cieśla, … Ewa Sitnicka·bioRxiv·Dec 11, 2024
- Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy
Carolyn Shasha, David Richard Glass, … Evan William Newell·BloodPeer-reviewed·Mar 31, 2025
- Single-cell transcriptional analysis of the immune tumour microenvironment during myeloma disease evolution
D. C. Croucher, L. M. Richards, … S. Trudel·bioRxiv·Oct 22, 2021